Cost-Effectiveness of Afatinib, Gefitinib, Erlotinib, and Pemetrexed-Based Chemotherapy as First-Line Treatments for Egfr Mutation Positive, Advanced Non-Small Cell Lung Cancer in China
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.243
https://www.valueinhealthjournal.com/article/S1098-3015(17)30577-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
221
First Page :
A440
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30577-6&doi=10.1016/j.jval.2017.08.243